SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-345602
Filing Date
2012-08-09
Accepted
2012-08-09 08:01:18
Documents
4
Period of Report
2012-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d393520d8k.htm 8-K 16467
2 PRESS RELEASE d393520dex991.htm EX-99.1 93679
3 GRAPHIC g393520sss.jpg GRAPHIC 5597
4 GRAPHIC g393520www.jpg GRAPHIC 5572
  Complete submission text file 0001193125-12-345602.txt   127100
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 121018548
SIC: 2834 Pharmaceutical Preparations